Ziccum AB Logo

Ziccum AB

ZICC | ST

Overview

Corporate Details

ISIN(s):
SE0011415595 (+3 more)
LEI:
5493005TADJBZHXP0U27
Country:
Sweden
Address:
Scheelevägen 22, 223 63 Lund
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Ziccum AB develops and licenses its proprietary drying technology, LaminarPace®. This platform uses mass transfer at ambient temperatures to formulate sensitive biologics and vaccines into thermostable, particle-engineered dry powders. The process avoids heat-related degradation, preserving the substance's efficacy and eliminating the need for complex cold chain logistics. The resulting powders are also suitable for novel administration routes. Ziccum's business model is focused on entering into license agreements and technology transfers with major pharmaceutical and biotherapeutic companies to integrate its technology into their product development and manufacturing.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Ziccum AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Ziccum AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Ziccum AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-12-13 Ann Gidner Other Buy 14,000 8,381.80 SEK

Peer Companies

Company Country Ticker View
Aran Research & Development (1982) Ltd. Logo
End-to-end product & machine development for plastics, medical, and industrial markets.
Israel ARAN
ARIX BIOSCIENCE PLC Logo United Kingdom ARIX
AroCell AB Logo Sweden AROC
Arterra Bioscience Logo
Develops sustainable active ingredients from plant cell cultures for diverse industries.
Italy ABS
Asarina Pharma AB Logo
Developed Sepranolone for neurological disorders like Tourette's, OCD, and menstrual migraine.
Sweden ASAP
Ascelia Pharma Logo
Developing novel drugs for rare cancer conditions, including an oral MRI contrast agent.
Sweden ACE
AVACTA GROUP PLC Logo
Developing targeted cancer therapies with a platform that delivers drugs directly to tumors.
United Kingdom AVCT
BenevolentAI Logo
AI-powered platform that analyzes biomedical data to accelerate drug discovery.
United Kingdom BAI
BerGenBio Logo
Develops first-in-class AXL inhibitors for cancer and severe respiratory infections.
Norway BGBIO
BioArctic Logo
Biopharma developing treatments & diagnostics for neurodegenerative diseases like Alzheimer's.
Sweden BIOA